References
- Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharma Sci, 2003;92(7):1343–55.
- Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer’s disease and the basal forebrain cholinergic system: Relations to β-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol, 2002;68(3):209–45.
- Chowdhary RK, Chansarkar N, Sharif I, Hioka N, Dolphin D. Formulation of benzoporphyrin derivatives in pluronics. Photochem Photobiol, 2003;77(3):299–303.
- Drewes G. MARKing tau for tangles and toxicity. Trends biochem Sci, 2004;29(10):548–55.
- Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol, 1961;7(2):88–95.
- Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys, 1959;82(1):70–7.
- Gaisford S, Beezer AE, Mitchell JC, Loh W, Finnie JK, Williams SJ. Diode-array UV spectrometric evidence for a concentration-dependent phase transition in dilute aqueous solutions of Pluronic F87 (poloxamer 237). J Chem Soc Chem Commun, 1995;(18):1843–4.
- Gaisford S, Beezer AE, Mitchell JC. Diode-array UV spectrometric evidence for cooperative interactions in binary mixtures of Pluronics F77, F87, and F127. Langmuir, 1997;13(10):2606–7.
- Giacobini E. Cholinesterase inhibitors: New roles and therapeutic alternatives. Pharmacol Res, 2004;50(4):433–40.
- Gong EJ, Park HR, Kim ME, Piao S, Lee E, Jo DG, Chung HY, Ha NC, Mattson MP, Lee J. Morin attenuates tau hyperphosphorylation by inhibiting GSK3β. Neurobiol Dis, 2011;44(2):223–30.
- Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem, 1982;126(1):131–8.
- Hao Y, Zhao F, Li N, Yang Y, Li KA. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharmaceut, 2002;244(1):73–80.
- Kabanov AV, Batrakova EV, Miller DW. Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Adv Drug Deliv Rev, 2003;55(1):151–64.
- Kumar MR, Muralidharan S. Method development and validation of Bio Flavanoid-morin hydrate by RP-HPLC in human plasma. J Young Pharm, 2015;7(3):194.
- Oh KT, Bronich TK, Kabanov AV. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic® block copolymers. J Control Release, 2004;94(2):411–22.
- Patil SS, Sunyer B, Höger H, Lubec G. Evaluation of spatial memory of C57BL/6J and CD1 mice in the Barnes maze, the Multiple T-maze and in the Morris water maze. Behav Brain Res, 2009;198(1):58–68.
- Sharma D, Bansal PK, Mishra N. Role of lipidic nanoparticles for management of Alzheimer’s diseases. Asian J Biomater Res, 2016;2(1):1–8.
- Tapia FJ, Barbosa AJ, Marangos PJ, Polak JM, Bloom SR, Dermody C, Pearse AG. Neuron-specific enolase is produced by neuroendocrine tumours. Lancet, 1981;1(8224):808–11.
- Thangarajan S, Deivasigamani A, Natarajan SS, Krishnan P, Mohanan SK. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum. Int J Neurosci, 2014;124(9):673–84.
- Wills ED. Mechanisms of lipid peroxide formation in animal tissues. Biochem. J, 1966;99(3):667
- Zhang J, Peng Q, Shi S, Zhang Q, Sun X, Gong T, Zhang Z. Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex. Int J Nanomed, 2011;6:3405.
- Zhang JA, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T, Ahmad I. Development and characterization of a novel Cremophor® EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharmaceut Biopharmaceut, 2005;59(1):177–87.
- Zumkley H, Bertram HP, Lison A, Knoll O, Losse H. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency. Clin Nephrol, 1979;12(1):18–21.